{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:57:35Z","timestamp":1775753855498,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03458-7","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:05:52Z","timestamp":1766073952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Revealing sphingolipid metabolism genes as biomarkers for the diagnosis of invasive pituitary adenomas in silico and in vivo"],"prefix":"10.1186","volume":"30","author":[{"given":"Zhi-jie","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruo-tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"issue":"4","key":"3458_CR1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/medicina59040812","volume":"59","author":"R Vamvoukaki","year":"2023","unstructured":"Vamvoukaki R, Chrysoulaki M, Betsi G, Xekouki P. Pituitary tumorigenesis-implications for management. Medicina (Kaunas). 2023;59(4):812. https:\/\/doi.org\/10.3390\/medicina59040812.","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"3458_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3892\/or.2021.8081","volume":"42","author":"Z Wang","year":"2019","unstructured":"Wang Z, Gao L, Guo X, Feng C, Deng K, Lian W, et al. Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis. Oncol Rep. 2019;42(2):533\u201348. https:\/\/doi.org\/10.3892\/or.2021.8081.","journal-title":"Oncol Rep"},{"issue":"3","key":"3458_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1507\/endocrj.EJ23-0007","volume":"70","author":"H Nishioka","year":"2023","unstructured":"Nishioka H. Aggressive pituitary tumors (PitNETs). Endocr J. 2023;70(3):241\u20138. https:\/\/doi.org\/10.1507\/endocrj.EJ23-0007.","journal-title":"Endocr J"},{"issue":"1","key":"3458_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/jnc.15044","volume":"158","author":"M Alaamery","year":"2021","unstructured":"Alaamery M, Albesher N, Aljawini N, Alsuwailm M, Massadeh S, Wheeler MA, et al. Role of sphingolipid metabolism in neurodegeneration. J Neurochem. 2021;158(1):25\u201335. https:\/\/doi.org\/10.1111\/jnc.15044.","journal-title":"J Neurochem"},{"issue":"10","key":"3458_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102910","volume":"12","author":"T Dowdy","year":"2020","unstructured":"Dowdy T, Zhang L, Celiku O, Movva S, Lita A, Ruiz-Rodado V, et al. Sphingolipid pathway as a source of vulnerability in IDH1mut glioma. Cancers (Basel). 2020;12(10):2910. https:\/\/doi.org\/10.3390\/cancers12102910.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3458_CR6","doi-asserted-by":"publisher","first-page":"13810","DOI":"10.1038\/s41598-023-41107-3","volume":"13","author":"G Liu","year":"2023","unstructured":"Liu G, Yang Y, Kang X, Xu H, Ai J, Cao M, et al. A pan-cancer analysis of lipid metabolic alterations in primary and metastatic cancers. Sci Rep. 2023;13(1):13810. https:\/\/doi.org\/10.1038\/s41598-023-41107-3.","journal-title":"Sci Rep"},{"issue":"22","key":"3458_CR7","doi-asserted-by":"publisher","first-page":"13818","DOI":"10.3390\/ijms232213818","volume":"23","author":"H Lee","year":"2022","unstructured":"Lee H, Kim D, Youn B. Targeting oncogenic rewiring of lipid metabolism for glioblastoma treatment. Int J Mol Sci. 2022;23(22):13818. https:\/\/doi.org\/10.3390\/ijms232213818.","journal-title":"Int J Mol Sci"},{"key":"3458_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1523902","volume":"12","author":"N Xiao","year":"2025","unstructured":"Xiao N, Huang X, Wu Y, Li B, Zang W, Shinwari K, et al. Opportunities and challenges with artificial intelligence in allergy and immunology: a bibliometric study. Front Med (Lausanne). 2025;12:1523902. https:\/\/doi.org\/10.3389\/fmed.2025.1523902.","journal-title":"Front Med (Lausanne)"},{"key":"3458_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s40484-019-0174-9","author":"G Liu","year":"2019","unstructured":"Liu G, Bolkov MA, Tuzankina IA, Danilova IG. Identification of candidate disease genes in patients with common variable immunodeficiency. Quant Biol. 2019. https:\/\/doi.org\/10.1007\/s40484-019-0174-9.","journal-title":"Quant Biol"},{"issue":"1","key":"3458_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327. https:\/\/doi.org\/10.1093\/biostatistics\/kxj037.","journal-title":"Biostatistics"},{"key":"3458_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.925072","volume":"14","author":"W Zhang","year":"2022","unstructured":"Zhang W, Shi G, Wang H, Feng M, Gao X, Xie Q, et al. Molecular mechanism of Xingnao Kaiqiao pill for perioperative neurocognitive disorder and its correlation with immune and inflammatory signaling pathways based on network pharmacology and molecular docking. Front Aging Neurosci. 2022;14:925072. https:\/\/doi.org\/10.3389\/fnagi.2022.925072.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3458_CR12","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1038\/s41467-018-07232-8","volume":"9","author":"SR Rosario","year":"2018","unstructured":"Rosario SR, Long MD, Affronti HC, Rowsam AM, Eng KH, Smiraglia DJ. Pan-cancer analysis of transcriptional metabolic dysregulation using the Cancer Genome Atlas. Nat Commun. 2018;9(1):5330. https:\/\/doi.org\/10.1038\/s41467-018-07232-8.","journal-title":"Nat Commun"},{"issue":"2","key":"3458_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4183\/aeb.2020.267","volume":"16","author":"I Burcea","year":"2020","unstructured":"Burcea I, Poiana C. Updates in aggressive pituitary tumors. Acta Endocrinol (Buchar). 2020;16(2):267\u201373. https:\/\/doi.org\/10.4183\/aeb.2020.267.","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"2","key":"3458_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11154-020-09563-8","volume":"21","author":"M Buchfelder","year":"2020","unstructured":"Buchfelder M, Schlaffer SM. Surgical treatment of aggressive pituitary adenomas and pituitary carcinomas. Rev Endocr Metab Disord. 2020;21(2):253\u201361. https:\/\/doi.org\/10.1007\/s11154-020-09563-8.","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"3458_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.23736\/S2724-6507.23.04058-7","volume":"49","author":"DDE Alcubierre","year":"2024","unstructured":"Alcubierre DDE, Carretti AL, Ducray F, Jouanneau E, Raverot G, Ilie MD. Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomide. Minerva Endocrinol (Torino). 2024;49(3):321\u201334. https:\/\/doi.org\/10.23736\/S2724-6507.23.04058-7.","journal-title":"Minerva Endocrinol (Torino)"},{"issue":"1","key":"3458_CR16","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.1038\/s41598-024-55917-6","volume":"14","author":"D Mustafov","year":"2024","unstructured":"Mustafov D, Siddiqui SS, Klena L, Karteris E, Braoudaki M. SV2B\/miR-34a\/miR-128 axis as prognostic biomarker in glioblastoma multiforme. Sci Rep. 2024;14(1):6647. https:\/\/doi.org\/10.1038\/s41598-024-55917-6.","journal-title":"Sci Rep"},{"issue":"18","key":"3458_CR17","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.3390\/cancers15184471","volume":"15","author":"G Cossu","year":"2023","unstructured":"Cossu G, La Rosa S, Brouland JP, Pitteloud N, Harel E, Santoni F, et al. PD-L1 expression in pituitary neuroendocrine tumors\/pituitary adenomas. Cancers (Basel). 2023;15(18):4471. https:\/\/doi.org\/10.3390\/cancers15184471.","journal-title":"Cancers (Basel)"},{"key":"3458_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/987-1-1-4419-6741-1_1","volume":"688","author":"CR Gault","year":"2010","unstructured":"Gault CR, Obeid LM, Hannun YA. An overview of sphingolipid metabolism: from synthesis to breakdown. Adv Exp Med Biol. 2010;688:1\u201323. https:\/\/doi.org\/10.1007\/987-1-1-4419-6741-1_1.","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"3458_CR19","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1080\/15548627.2021.1874208","volume":"17","author":"N Meyer","year":"2021","unstructured":"Meyer N, Henkel L, Linder B, Zielke S, Tascher G, Trautmann S, et al. Autophagy activation, lipotoxicity and lysosomal membrane permeabilization synergize to promote pimozide- and loperamide-induced glioma cell death. Autophagy. 2021;17(11):3424\u201343. https:\/\/doi.org\/10.1080\/15548627.2021.1874208.","journal-title":"Autophagy"},{"issue":"5","key":"3458_CR20","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.18103\/mra.v9i5.2433","volume":"9","author":"EA Kolar","year":"2021","unstructured":"Kolar EA, Shi X, Clay EM, Moser AB, Lal B, Nirujogi RS, et al. Very long-chain acyl-CoA synthetase 3 mediates onco-sphingolipid metabolism in malignant glioma. Med Res Arch. 2021;9(5):2433. https:\/\/doi.org\/10.18103\/mra.v9i5.2433.","journal-title":"Med Res Arch"},{"key":"3458_CR21","doi-asserted-by":"publisher","first-page":"1191262","DOI":"10.3389\/fphar.2023.1191262","volume":"14","author":"A Lavoro","year":"2023","unstructured":"Lavoro A, Falzone L, Tomasello B, Conti GN, Libra M, Candido S. In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity. Front Pharmacol. 2023;14:1191262. https:\/\/doi.org\/10.3389\/fphar.2023.1191262.","journal-title":"Front Pharmacol"},{"issue":"2\u20133","key":"3458_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.mam.2012.07.010","volume":"34","author":"CM Anderson","year":"2013","unstructured":"Anderson CM, Stahl A. SLC27 fatty acid transport proteins. Mol Aspects Med. 2013;34(2\u20133):516\u201328. https:\/\/doi.org\/10.1016\/j.mam.2012.07.010.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"3458_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12885-023-10816-3","volume":"23","author":"K Shang","year":"2023","unstructured":"Shang K, Ma N, Che J, Li H, Hu J, Sun H, et al. SLC27A2 mediates FAO in colorectal cancer through nongenic crosstalk regulation of the PPARs pathway. BMC Cancer. 2023;23(1):335. https:\/\/doi.org\/10.1186\/s12885-023-10816-3.","journal-title":"BMC Cancer"},{"issue":"1","key":"3458_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24148","volume":"36","author":"K Feng","year":"2022","unstructured":"Feng K, Ma R, Li H, Yin K, Du G, Chen X, et al. Upregulated SLC27A2\/FATP2 in differentiated thyroid carcinoma promotes tumor proliferation and migration. J Clin Lab Anal. 2022;36(1):e24148. https:\/\/doi.org\/10.1002\/jcla.24148.","journal-title":"J Clin Lab Anal"},{"key":"3458_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101952","volume":"45","author":"L Lu","year":"2024","unstructured":"Lu L, Li J, Zheng Y, Luo L, Huang Y, Hu J, et al. High expression of SLC27A2 predicts unfavorable prognosis and promotes inhibitory immune infiltration in acute lymphoblastic leukemia. Transl Oncol. 2024;45:101952. https:\/\/doi.org\/10.1016\/j.tranon.2024.101952.","journal-title":"Transl Oncol"},{"issue":"5","key":"3458_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00432-024-05754-x","volume":"150","author":"B Zhang","year":"2024","unstructured":"Zhang B, Zhang Y, Chang K, Hou N, Fan P, Ji C, et al. Risk assessment model based on nucleotide metabolism-related genes highlights SLC27A2 as a potential therapeutic target in breast cancer. J Cancer Res Clin Oncol. 2024;150(5):258. https:\/\/doi.org\/10.1007\/s00432-024-05754-x.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"3458_CR27","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/brainsci13050771","volume":"13","author":"J Korbecki","year":"2023","unstructured":"Korbecki J, Kojder K, Je\u017cewski D, Simi\u0144ska D, Tomasiak P, Tarnowski M, et al. Reduced expression of very-long-chain acyl-CoA synthetases SLC27A4 and SLC27A6 in the glioblastoma tumor compared to the peritumoral area. Brain Sci. 2023;13(5):771. https:\/\/doi.org\/10.3390\/brainsci13050771.","journal-title":"Brain Sci"},{"issue":"Pt 3","key":"3458_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1242\/jcs.037051","volume":"122","author":"N Naslavsky","year":"2009","unstructured":"Naslavsky N, McKenzie J, Altan-Bonnet N, Sheff D, Caplan S. EHD3 regulates early-endosome-to-Golgi transport and preserves Golgi morphology. J Cell Sci. 2009;122(Pt 3):389\u2013400. https:\/\/doi.org\/10.1242\/jcs.037051.","journal-title":"J Cell Sci"},{"issue":"26","key":"3458_CR29","doi-asserted-by":"publisher","first-page":"13465","DOI":"10.1074\/jbc.M116.716407","volume":"291","author":"K Bahl","year":"2016","unstructured":"Bahl K, Xie S, Spagnol G, Sorgen P, Naslavsky N, Caplan S. EHD3 protein is required for tubular recycling endosome stabilization, and an asparagine-glutamic acid residue pair within its Eps15 homology (EH) domain dictates its selective binding to NPF peptides. J Biol Chem. 2016;291(26):13465\u201378. https:\/\/doi.org\/10.1074\/jbc.M116.716407.","journal-title":"J Biol Chem"},{"issue":"8","key":"3458_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1034\/j.1600-0854.2002.30807.x","volume":"3","author":"E Galperin","year":"2002","unstructured":"Galperin E, Benjamin S, Rapaport D, Rotem-Yehudar R, Tolchinsky S, Horowitz M. EHD3: a protein that resides in recycling tubular and vesicular membrane structures and interacts with EHD1. Traffic. 2002;3(8):575\u201389. https:\/\/doi.org\/10.1034\/j.1600-0854.2002.30807.x.","journal-title":"Traffic"},{"issue":"1","key":"3458_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2016.02.011","volume":"342","author":"Y Henmi","year":"2016","unstructured":"Henmi Y, Oe N, Kono N, Taguchi T, Takei K, Tanabe K. Phosphatidic acid induces EHD3-containing membrane tubulation and is required for receptor recycling. Exp Cell Res. 2016;342(1):1\u201310. https:\/\/doi.org\/10.1016\/j.yexcr.2016.02.011.","journal-title":"Exp Cell Res"},{"issue":"9","key":"3458_CR32","first-page":"4401","volume":"13","author":"J Yu","year":"2023","unstructured":"Yu J, Yan Y, Hua C, Song H. EHD3 promotes gastric cancer progression via Wnt\/\u03b2-catenin\/EMT pathway and associates with clinical prognosis and immune infiltration. Am J Cancer Res. 2023;13(9):4401\u201317 (PMID: 37818061).","journal-title":"Am J Cancer Res"},{"issue":"9","key":"3458_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjad054","volume":"15","author":"I Paulussen","year":"2024","unstructured":"Paulussen I, Beckert H, Musial TF, Gschossmann LJ, Wolf J, Schmitt M, et al. SV2B defines a subpopulation of synaptic vesicles. J Mol Cell Biol. 2024;15(9):mjad054. https:\/\/doi.org\/10.1093\/jmcb\/mjad054.","journal-title":"J Mol Cell Biol"},{"issue":"6","key":"3458_CR34","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1073\/pnas.90.6.2150","volume":"90","author":"SM Bajjalieh","year":"1993","unstructured":"Bajjalieh SM, Peterson K, Linial M, Scheller RH. Brain contains two forms of synaptic vesicle protein 2. Proc Natl Acad Sci U S A. 1993;90(6):2150\u20134. https:\/\/doi.org\/10.1073\/pnas.90.6.2150.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3458_CR35","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20201625","volume":"40","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Yang X, Zhu XL, Hao JQ, Bai H, Xiao YC, et al. Bioinformatics analysis of potential core genes for glioblastoma. Biosci Rep. 2020;40(7):BSR20201625. https:\/\/doi.org\/10.1042\/BSR20201625.","journal-title":"Biosci Rep"},{"issue":"1","key":"3458_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13073-023-01267-3","volume":"16","author":"N Yan","year":"2024","unstructured":"Yan N, Xie W, Wang D, Fang Q, Guo J, Chen Y, et al. Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors. Genome Med. 2024;16(1):2. https:\/\/doi.org\/10.1186\/s13073-023-01267-3.","journal-title":"Genome Med"},{"issue":"2","key":"3458_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1385\/ep:15:2:131","volume":"15","author":"K Takada","year":"2004","unstructured":"Takada K, Yamada S, Teramoto A. Correlation between tumor vascularity and clinical findings in patients with pituitary adenomas. Endocr Pathol. 2004;15(2):131\u20139. https:\/\/doi.org\/10.1385\/ep:15:2:131.","journal-title":"Endocr Pathol"},{"issue":"2","key":"3458_CR38","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jemt.10263","volume":"60","author":"RV Lloyd","year":"2003","unstructured":"Lloyd RV, Vidal S, Horvath E, Kovacs K, Scheithauer B. Angiogenesis in normal and neoplastic pituitary tissues. Microsc Res Tech. 2003;60(2):244\u201350. https:\/\/doi.org\/10.1002\/jemt.10263.","journal-title":"Microsc Res Tech"},{"issue":"21","key":"3458_CR39","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182\u20136. https:\/\/doi.org\/10.1056\/NEJM197111182852108.","journal-title":"N Engl J Med"},{"issue":"3","key":"3458_CR40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11060-014-1377-6","volume":"117","author":"F Matano","year":"2014","unstructured":"Matano F, Yoshida D, Ishii Y, Tahara S, Teramoto A, Morita A. Endocan, a new invasion and angiogenesis marker of pituitary adenomas. J Neurooncol. 2014;117(3):485\u201391. https:\/\/doi.org\/10.1007\/s11060-014-1377-6.","journal-title":"J Neurooncol"},{"key":"3458_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3389\/fendo.2019.00657","volume":"10","author":"Q Yang","year":"2019","unstructured":"Yang Q, Li X. Molecular network basis of invasive pituitary adenoma: a review. Front Endocrinol (Lausanne). 2019;10:657. https:\/\/doi.org\/10.3389\/fendo.2019.00657.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"3458_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1530\/ERC-19-0327","volume":"26","author":"P Marques","year":"2019","unstructured":"Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Awad S, et al. Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness. Endocr Relat Cancer. 2019;26(12):853\u201365. https:\/\/doi.org\/10.1530\/ERC-19-0327.","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"3458_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/biology14050479","volume":"14","author":"G Liu","year":"2025","unstructured":"Liu G, Shi Y, Huang H, Xiao N, Liu C, Zhao H, et al. FPCAM: a weighted dictionary-driven model for single-cell annotation in pulmonary fibrosis. Biology. 2025;14(5):479. https:\/\/doi.org\/10.3390\/biology14050479.","journal-title":"Biology"},{"key":"3458_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbi.2015.07.007","volume":"50","author":"E Glennon","year":"2015","unstructured":"Glennon E, Kaunzner UW, Gagnidze K, McEwen BS, Bulloch K. Pituitary dendritic cells communicate immune pathogenic signals. Brain Behav Immun. 2015;50:232\u201340. https:\/\/doi.org\/10.1016\/j.bbi.2015.07.007.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"3458_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11060-020-03636-z","volume":"149","author":"W Zhou","year":"2020","unstructured":"Zhou W, Zhang C, Zhang D, Peng J, Ma S, Wang X, et al. Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas. J Neurooncol. 2020;149(3):473\u201387. https:\/\/doi.org\/10.1007\/s11060-020-03636-z.","journal-title":"J Neurooncol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03458-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03458-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03458-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:05:53Z","timestamp":1766073953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03458-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3458"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03458-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Institutional Ethics Committee of Baoding No.1 Central Hospital (Approval number: Quick [2024]-155). The patients\/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1243"}}